Moderna’s (MRNA) adjusted EPS came in at -$3.07 versus an estimated -$3.59 and revenue came in at $167.00M versus an estimated $124.74M. CFO Jamey Mock joins Oliver Renick to discuss Moderna’s 1Q earnings and the outlook for the company. He also talks about Moderna’s product pipeline. Tune in to find out more about the stock market today.